Stem Cells for the Treatment of Neurodegenerative Diseases
Abstract
:1. Introduction
2. Stem Cell and Neurodegenerative Diseases
2.1. Stem cells and Parkinson’s disease
2.2. Stem cells and Huntington's disease
2.3. Stem cells and Alzheimer's disease
2.4. Stem cells and Amyotrophic Lateral Sclerosis
2.5. Stems cell and stroke
2.6. Stem cells and spinal cord injury
3. Conclusions
Acknowledgments
References
- Kim, S.U.; de Vellis, J. Stem cell-based cell therapy in neurological diseases: a review. J. Neurosci. Res. 2009, 87, 2183–2200. [Google Scholar] [CrossRef] [PubMed]
- Lindvall, O.; Kokaia, Z.; Martinez-Serrano, A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 2004, 10, S42–S50. [Google Scholar] [CrossRef] [PubMed]
- Cui, Y.F.; Hargus, G.; Xu, J.C.; Schmid, J.S.; Shen, Y.Q.; Glatzel, M.; Schachner, M.; Bernreuther, C. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Brain 2010, 133, 189–204. [Google Scholar] [CrossRef] [PubMed]
- Grunt, R.F. Embryonic stem-cell research. N. Engl. J. Med. 2004, 351, 1797–1798. [Google Scholar] [PubMed]
- Daley, G.Q. Missed opportunities in embryonic stem-cell research. N. Engl. J. Med. 2004, 351, 627–628. [Google Scholar] [CrossRef] [PubMed]
- Yang, D.; Zhang, Z.J.; Oldenburg, M.; Ayala, M.; Zhang, S.C. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 2008, 26, 55–63. [Google Scholar] [CrossRef] [PubMed]
- Glass, C.K.; Saijo, K.; Winner, B.; Marchetto, M.C.; Gage, F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140, 918–934. [Google Scholar] [CrossRef] [PubMed]
- Dawson, T.M.; Dawson, V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003, 302, 819–822. [Google Scholar] [CrossRef] [PubMed]
- Burnstein, R.M.; Foltynie, T.; He, X.; Menon, D.K.; Svendsen, C.N.; Caldwell, M.A. Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease. Int. J. Biochem. Cell Biol. 2004, 36, 702–713. [Google Scholar] [CrossRef] [PubMed]
- Kim, J.H.; Auerbach, J.M.; Rodriguez-Gomez, J.A.; Velasco, I.; Gavin, D.; Lumelsky, N.; Lee, S.H.; Nguyen, J.; Sanchez-Pernaute, R.; Bankiewicz, K.; McKay, R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002, 418, 50–56. [Google Scholar] [CrossRef] [PubMed]
- Prokai-Tatrai, K.; Prokai, L. Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents. Molecules 2009, 14, 633–654. [Google Scholar] [CrossRef] [PubMed]
- Prokai-Tatrai, K.; Perjesi, P.; Rivera-Portalatin, N.M.; Simpkins, J.W.; Prokai, L. Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative. Steroids 2008, 73, 280–288. [Google Scholar] [CrossRef] [PubMed]
- Cova, L.; Armentero, M.T.; Zennaro, E.; Calzarossa, C.; Bossolasco, P.; Busca, G.; Lambertenghi Deliliers, G.; Polli, E.; Nappi, G.; Silani, V.; Blandini, F. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res. 2010, 1311, 12–27. [Google Scholar] [CrossRef] [PubMed]
- Venkataramana, N.K.; Kumar, S.K.; Balaraju, S.; Radhakrishnan, R.C.; Bansal, A.; Dixit, A.; Rao, D.K.; Das, M.; Jan, M.; Gupta, P.K.; Totey, S.M. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl. Res. 2010, 155, 62–70. [Google Scholar] [CrossRef] [PubMed]
- Hedlund, E.; Pruszak, J.; Lardaro, T.; Ludwig, W.; Vinuela, A.; Kim, K.S.; Isacson, O. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 2008, 26, 1526–1536. [Google Scholar] [CrossRef] [PubMed]
- Mine, Y.; Hayashi, T.; Yamada, M.; Okano, H.; Kawase, T. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain. Neurosurgery 2009, 65, 741–753. [Google Scholar] [CrossRef] [PubMed]
- McLeod, M.; Hong, M.; Mukhida, K.; Sadi, D.; Ulalia, R.; Mendez, I. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease. Eur. J. Neurosci. 2006, 24, 361–370. [Google Scholar] [CrossRef] [PubMed]
- Ourednik, V.; Ourednik, J.; Xu, Y.F.; Zhang, Y.; Lynch, W.P.; Snyder, E.Y.; Schachner, M. Cross-Talk Between Stem Cells and the Dysfunctional Brain is Facilitated by Manipulating the Niche: Evidence from an Adhesion Molecule. Stem Cells 2009, 27, 2846–2856. [Google Scholar] [CrossRef] [PubMed]
- Oizumi, H.; Hayashita-Kinoh, H.; Hayakawa, H.; Arai, H.; Furuya, T.; Ren, Y.R.; Yasuda, T.; Seki, T.; Mizuno, Y.; Mochizuki, H. Alteration in the differentiation-related molecular expression in the subventricular zone in a mouse model of Parkinson's disease. Neurosci. Res. 2008, 60, 15–21. [Google Scholar] [CrossRef] [PubMed]
- Isacson, O. Cell therapy ahead for Parkinson's disease. Science 2009, 326, 1060. [Google Scholar] [CrossRef] [PubMed]
- Akerud, P.; Holm, P.C.; Castelo-Branco, G.; Sousa, K.; Rodriguez, F.J.; Arenas, E. Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease. Mol. Cell. Neurosci. 2002, 21, 205–222. [Google Scholar] [PubMed]
- Shin, J.H.; Dawson, V.L.; Dawson, T.M. SnapShot: Pathogenesis of Parkinson's Disease. Cell 2009, 139, e1–e2. [Google Scholar] [CrossRef] [PubMed]
- Marchetto, M.C.; Winner, B.; Gage, F.H. Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum. Mol. Genet. 2010, 19, R71–R76. [Google Scholar] [CrossRef] [PubMed]
- Nakamura, T.; Lipton, S.A. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases. Apoptosis 2010. [Google Scholar] [CrossRef] [PubMed]
- Steiner, B.; Wolf, S.; Kempermann, G. Adult neurogenesis and neurodegenerative disease. Regen. Med. 2006, 1, 15–28. [Google Scholar] [CrossRef] [PubMed]
- Zietlow, R.; Lane, E.L.; Dunnett, S.B.; Rosser, A.E. Human stem cells for CNS repair. Cell Tissue Res. 2008, 331, 301–322. [Google Scholar] [CrossRef] [PubMed]
- Dunnett, S.B.; Rosser, A.E. Stem cell transplantation for Huntington's disease. Exp. Neurol. 2007, 203, 279–292. [Google Scholar] [CrossRef] [PubMed]
- Kim, M.; Lee, S.T.; Chu, K.; Kim, S.U. Stem cell-based cell therapy for Huntington disease: a review. Neuropathology 2008, 28, 1–9. [Google Scholar] [CrossRef] [PubMed]
- McKay, R. Stem cells in the central nervous system. Science 1997, 276, 66–71. [Google Scholar] [CrossRef] [PubMed]
- Keene, C.D.; Rodrigues, C.M.P.; Eich, T.; Chhabra, M.S.; Steer, C.J.; Low, W.C. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic model of Huntington's disease. Proc. Natl. Acad. Sci. USA 2002, 99, 10671–10676. [Google Scholar] [CrossRef] [PubMed]
- Ramaswamy, S.; Shannon, K.M.; Kordower, J.H. Huntington's disease: Pathological mechanisms and therapeutic strategies. Cell Transplant. 2007, 16, 301–312. [Google Scholar] [CrossRef] [PubMed]
- Johann, V.; Schiefer, J.; Sass, C.; Mey, J.; Brook, G.; Kruttgen, A.; Schlangen, C.; Bernreuther, C.; Schachner, M.; Dihne, M.; Kosinski, C.M. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease. Exp. Brain Res. 2007, 177, 458–470. [Google Scholar] [CrossRef] [PubMed]
- Cherubini, A.; Spoletini, I.; Peran, P.; Luccichenti, G.; Di Paola, M.; Sancesario, G.; Gianni, W.; Giubilei, F.; Bossu, P.; Sabatini, U.; Caltagirone, C.; Spalletta, G. A multimodal MRI investigation of the subventricular zone in mild cognitive impairment and Alzheimer's disease patients. Neurosci. Lett. 2010, 469, 214–218. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.M.; Singh, C.; Liu, L.; Irwin, R.W.; Chen, S.; Chung, E.J.; Thompson, R.F.; Brinton, R.D. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2010, 107, 6498–6503. [Google Scholar] [CrossRef] [PubMed]
- McBride, J.L.; Behrstock, S.P.; Chen, E.Y.; Jakel, R.J.; Siegel, I.; Svendsen, C.N.; Kordower, J.H. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J. Comp. Neurol. 2004, 475, 211–219. [Google Scholar] [CrossRef] [PubMed]
- Snyder, B.R.; Chiu, A.M.; Prockop, D.J.; Chan, A.W. Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease. Plos One 2010, 5, e9347. [Google Scholar] [CrossRef] [PubMed]
- Krystkowiak, P.; Gaura, V.; Labalette, M.; Rialland, A.; Remy, P.; Peschanski, M.; Bachoud-Levi, A.C. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. Plos One 2007, 2, e166. [Google Scholar] [CrossRef] [PubMed]
- Lorincz, M.T.; Zawistowski, V.A. Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells. Mol. Cell Neurosci. 2009, 40, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.U. Genetically engineered human neural stem cells for brain repair in neurological diseases. Brain Develop 2007, 29, 193–201. [Google Scholar] [CrossRef] [PubMed]
- Clelland, C.D.; Barker, R.A.; Watts, C. Cell therapy in Huntington disease. Neurosurg. Focus 2008, 24, E9. [Google Scholar] [CrossRef] [PubMed]
- Ebert, A.D.; Barber, A.E.; Heins, B.M.; Svendsen, C.N. Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease. Exp. Neurol. 2010, 224, 155–162. [Google Scholar] [CrossRef] [PubMed]
- Yang, C.R.; Yu, R.K. Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease. J. Neurosci. Res. 2009, 87, 26–33. [Google Scholar] [CrossRef] [PubMed]
- Roberts, T.J.; Price, J.; Williams, S.C.; Modo, M. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. Neuroscience 2006, 139, 1187–1199. [Google Scholar] [CrossRef] [PubMed]
- McBride, J.L.; Ramaswamy, S.; Gasmi, M.; Bartus, R.T.; Herzog, C.D.; Brandon, E.P.; Zhou, L.; Pitzer, M.R.; Berry-Kravis, E.M.; Kordower, J.H. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 2006, 103, 9345–9350. [Google Scholar] [CrossRef] [PubMed]
- Laowtammathron, C.; Cheng, E.; Cheng, P.H.; Snyder, B.R.; Yang, S.H.; Johnson, Z.; Lorthongpanich, C.; Kuo, H.C.; Parnpai, R.; Chan, A.W. Monkey hybrid stem cells develop cellular features of Huntington's disease. BMC Cell Biol. 2010, 11, 12. [Google Scholar] [CrossRef] [PubMed]
- Mareschi, K.; Novara, M.; Rustichelli, D.; Ferrero, I.; Guido, D.; Carbone, E.; Medico, E.; Madon, E.; Vercelli, A.; Fagioli, F. Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types. Exp. Hematol. 2006, 34, 1563–1572. [Google Scholar] [CrossRef] [PubMed]
- Pineda, J.R.; Rubio, N.; Akerud, P.; Urban, N.; Badimon, L.; Arenas, E.; Alberch, J.; Blanco, J.; Canals, J.M. Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells. Gene Ther. 2007, 14, 118–128. [Google Scholar] [CrossRef] [PubMed]
- Molero, A.E.; Gokhan, S.; Gonzalez, S.; Feig, J.L.; Alexandre, L.C.; Mehler, M.F. Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease. Proc. Natl. Acad. Sci. USA 2009, 106, 21900–21905. [Google Scholar] [CrossRef] [PubMed]
- Huang, A.H.; Snyder, B.R.; Cheng, P.H.; Chan, A.W. Putative dental pulp-derived stem/stromal cells promote proliferation and differentiation of endogenous neural cells in the hippocampus of mice. Stem Cells 2008, 26, 2654–2663. [Google Scholar] [CrossRef] [PubMed]
- Bantubungi, K.; Blum, D.; Cuvelier, L.; Wislet-Gendebien, S.; Rogister, B.; Brouillet, E.; Schiffmann, S.N. Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease. Mol. Cell Neurosci. 2008, 37, 454–470. [Google Scholar] [CrossRef] [PubMed]
- Oliveira, A.A., Jr.; Hodges, H.M. Alzheimer's disease and neural transplantation as prospective cell therapy. Curr. Alzheimer Res. 2005, 2, 79–95. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.K.; Jin, H.K.; Endo, S.; Schuchman, E.H.; Carter, J.E.; Bae, J.S. Intracerebral Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Amyloid-Beta Deposition and Rescues Memory Deficits in Alzheimer's Disease Mice by Modulation of Immune Responses. Stem Cells 2010, 28, 329–343. [Google Scholar] [CrossRef] [PubMed]
- Blurton-Jones, M.; Kitazawa, M.; Martinez-Coria, H.; Castello, N.A.; Muller, F.J.; Loring, J.F.; Yamasaki, T.R.; Poon, W.W.; Green, K.N.; LaFerla, F.M. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. USA 2009, 106, 13594–13599. [Google Scholar] [CrossRef] [PubMed]
- Wu, S.; Sasaki, A.; Yoshimoto, R.; Kawahara, Y.; Manabe, T.; Kataoka, K.; Asashima, M.; Yuge, L. Neural stem cells improve learning and memory in rats with Alzheimer's disease. Pathobiology 2008, 75, 186–194. [Google Scholar] [CrossRef] [PubMed]
- Ryu, J.K.; Cho, T.; Wang, Y.T.; McLarnon, J.G. Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain. J. Neuroinflammation 2009, 6, 39. [Google Scholar] [CrossRef] [PubMed]
- Wu, L.; Sluiter, A.A.; Guo, H.F.; Balesar, R.A.; Swaab, D.F.; Zhou, J.N.; Verwer, R.W. Neural stem cells improve neuronal survival in cultured postmortem brain tissue from aged and Alzheimer patients. J. Cell Mol. Med. 2008, 12, 1611–1621. [Google Scholar] [CrossRef] [PubMed]
- Bergmans, B.A.; Shariati, S.A.M.; Habets, R.L.P.; Verstreken, P.; Schoonjans, L.; Muller, U.; Dotti, C.G.; De Strooper, B. Neurons Generated from APP/APLP1/APLP2 Triple Knockout Embryonic Stem Cells Behave Normally in Vitro and in Vivo: Lack of Evidence for a Cell Autonomous Role of the Amyloid Precursor Protein in Neuronal Differentiation. Stem Cells 2010, 28, 399–406. [Google Scholar] [PubMed]
- Zhongling, F.; Gang, Z.; Lei, Y. Neural stem cells and Alzheimer's disease: challenges and hope. Am. J. Alzheimers Dis. Other Demen. 2009, 24, 52–57. [Google Scholar] [CrossRef] [PubMed]
- Holtzman, D.M. Alzheimer's disease: Moving towards a vaccine. Nature 2008, 454, 418–420. [Google Scholar] [CrossRef] [PubMed]
- Waldau, B.; Shetty, A.K. Behavior of neural stem cells in the Alzheimer brain. Cell Mol. Life Sci. 2008, 65, 2372–2384. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.K.; Jin, H.K.; Bae, J.S. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci. Lett. 2009, 450, 136–141. [Google Scholar] [CrossRef] [PubMed]
- Wang, Q.; Matsumoto, Y.; Shindo, T.; Miyake, K.; Shindo, A.; Kawanishi, M.; Kawai, N.; Tamiya, T.; Nagao, S. Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease. J. Med. Invest. 2006, 53, 61–69. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.J.; Lee, J.K.; Lee, H.; Carter, J.E.; Chang, J.W.; Oh, W.; Yang, Y.S.; Suh, J.G.; Lee, B.H.; Jin, H.K.; Bae, J.S. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. Neurobiol. Aging 2010. [Google Scholar] [CrossRef] [PubMed]
- Salloway, S.; Mintzer, J.; Weiner, M.F.; Cummings, J.L. Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement. 2008, 4, 65–79. [Google Scholar] [CrossRef] [PubMed]
- Sugaya, K. Possible use of autologous stem cell therapies for Alzheimer disease. Neurobiol. Aging 2004, 25, S24–S25. [Google Scholar] [CrossRef]
- Xuan, A.G.; Luo, M.; Ji, W.D.; Long, D.H. Effects of engrafted neural stem cells in Alzheimer's disease rats. Neurosci. Lett. 2009, 450, 167–171. [Google Scholar] [CrossRef] [PubMed]
- Imitola, J. Prospects for neural stem cell-based therapies for neurological diseases. Neurotherapeutics 2007, 4, 701–714. [Google Scholar] [CrossRef] [PubMed]
- Sugaya, K.; Merchant, S. How to Approach Alzheimer's Disease Therapy Using Stem Cell Technologies. J. Alzheimers Dis. 2008, 15, 241–254. [Google Scholar] [CrossRef] [PubMed]
- Santilli, G.; Lamorte, G.; Carlessi, L.; Ferrari, D.; Rota Nodari, L.; Binda, E.; Delia, D.; Vescovi, A.L.; De Filippis, L. Mild hypoxia enhances proliferation and multipotency of human neural stem cells. Plos One 2010, 5, e8575. [Google Scholar] [CrossRef] [PubMed]
- Heese, K.; Low, J.W.; Inoue, N. Nerve growth factor, neural stem cells and Alzheimer's disease. Neurosignals 2006, 15, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Mucke, L. Neuroscience: Alzheimer's disease. Nature 2009, 461, 895–897. [Google Scholar] [CrossRef] [PubMed]
- Sugaya, K.; Kwak, Y.D.; Ohmitsu, O.; Marutle, A.; Greig, N.H.; Choumrina, E. Practical issues in stem cell therapy for Alzheimer's disease. Curr. Alzheimer Res. 2007, 4, 370–377. [Google Scholar] [CrossRef] [PubMed]
- Giacobini, E.; Becker, R.E. One hundred years after the discovery of Alzheimer's disease. A turning point for therapy? J. Alzheimers Dis. 2007, 12, 37–52. [Google Scholar] [CrossRef] [PubMed]
- Papadeas, S.T.; Maragakis, N.J. Advances in stem cell research for Amyotrophic Lateral Sclerosis. Curr. Opin. Biotechnol. 2009, 20, 545–551. [Google Scholar] [CrossRef] [PubMed]
- Yan, J.; Xu, L.; Welsh, A.M.; Chen, D.; Hazel, T.; Johe, K.; Koliatsos, V.E. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 2006, 24, 1976–1985. [Google Scholar] [CrossRef] [PubMed]
- Silani, V.; Calzarossa, C.; Cova, L.; Ticozzi, N. Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement? CNS Neurol. Disord. Drug Target. 2010, 9, 314–324. [Google Scholar] [CrossRef]
- Silani, V.; Cova, L.; Corbo, M.; Ciammola, A.; Polli, E. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 2004, 364, 200–202. [Google Scholar] [CrossRef]
- Yang, E.J.; Jiang, J.H.; Lee, S.M.; Hwang, H.S.; Lee, M.S.; Choi, S.M. Electroacupuncture reduces neuroinflammatory responses in symptomatic amyotrophic lateral sclerosis model. J. Neuroimmunol. 2010, 223, 84–91. [Google Scholar] [CrossRef] [PubMed]
- Thonhoff, J.R.; Ojeda, L.; Wu, P. Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis. Curr. Stem Cell Res. Ther. 2009, 4, 178–199. [Google Scholar] [CrossRef] [PubMed]
- Lepore, A.C.; Maragakis, N.J. Targeted stem cell transplantation strategies in ALS. Neurochem. Int. 2007, 50, 966–975. [Google Scholar] [CrossRef] [PubMed]
- de Aguilar, J.L.G.; Echaniz-Laguna, A.; Fergani, A.; Rene, F.; Meininger, V.; Loeffler, J.P.; Dupuis, L. Amyotrophic lateral sclerosis: all roads lead to Rome. J. Neurochem. 2007, 101, 1153–1160. [Google Scholar] [CrossRef] [PubMed]
- Neusch, C.; Bahr, M.; Schneider-Gold, C. Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease? Muscle Nerve 2007, 35, 712–724. [Google Scholar] [CrossRef] [PubMed]
- Karumbayaram, S.; Kelly, T.K.; Paucar, A.A.; Roe, A.J.; Umbach, J.A.; Charles, A.; Goldman, S.A.; Kornblum, H.I.; Wiedau-Pazos, M. Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS. Dis. Model Mech. 2009, 2, 189–195. [Google Scholar] [CrossRef] [PubMed]
- Di Giorgio, F.P.; Boulting, G.L.; Bobrowicz, S.; Eggan, K.C. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 2008, 3, 637–648. [Google Scholar] [CrossRef] [PubMed]
- Vercelli, A.; Mereuta, O.M.; Garbossa, D.; Muraca, G.; Mareschi, K.; Rustichelli, D.; Ferrero, I.; Mazzini, L.; Madon, E.; Fagioli, F. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2008, 31, 395–405. [Google Scholar] [CrossRef] [PubMed]
- Calvo, A.; Moglia, C.; Balma, M.; Chio, A. Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: a therapeutic opportunity? CNS Neurol. Disord. Drug Target. 2010, 9, 325–330. [Google Scholar] [CrossRef]
- Suzuki, M.; McHugh, J.; Tork, C.; Shelley, B.; Klein, S.M.; Aebischer, P.; Svendsen, C.N. GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALS. Plos One 2007, 2, e689. [Google Scholar] [CrossRef] [PubMed]
- Inoue, H. Neurodegenerative disease-specific induced pluripotent stem cell research. Exp. Cell Res. 2010, 316, 2560–2564. [Google Scholar] [CrossRef]
- Mazzini, L.; Ferrero, I.; Luparello, V.; Rustichelli, D.; Gunetti, M.; Mareschi, K.; Testa, L.; Stecco, A.; Tarletti, R.; Miglioretti, M.; Fava, E.; Nasuelli, N.; Cisari, C.; Massara, M.; Vercelli, R.; Oggioni, G.D.; Carriero, A.; Cantello, R.; Monaco, F.; Fagioli, F. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp. Neurol. 2010, 223, 229–237. [Google Scholar] [CrossRef] [PubMed]
- Mazzini, L.; Vercelli, A.; Mareschi, K.; Ferrero, I.; Testa, L.; Fagioli, F. Mesenchymal stem cells for ALS patients. Amyotroph. Lateral Scler. 2009, 10, 123–124. [Google Scholar] [CrossRef] [PubMed]
- Corti, S.; Locatelli, F.; Papadimitriou, D.; Del Bo, R.; Nizzardo, M.; Nardini, M.; Donadoni, C.; Salani, S.; Fortunato, F.; Strazzer, S.; Bresolin, N.; Comi, G.P. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain 2007, 130, 1289–1305. [Google Scholar] [CrossRef] [PubMed]
- Boillee, S.; Vande Velde, C.; Cleveland, D.W. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52, 39–59. [Google Scholar] [CrossRef] [PubMed]
- Kim, H.; Kim, H.Y.; Choi, M.R.; Hwang, S.; Nam, K.H.; Kim, H.C.; Han, J.S.; Kim, K.S.; Yoon, H.S.; Kim, S.H. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci. Lett. 2010, 468, 190–194. [Google Scholar] [CrossRef] [PubMed]
- Garbuzova-Davis, S.; Sanberg, P.R. Feasibility of cell therapy for amyotrophic lateral sclerosis. Exp. Neurol. 2009, 216, 3–6. [Google Scholar] [CrossRef] [PubMed]
- Choi, M.R.; Kim, H.Y.; Park, J.Y.; Lee, T.Y.; Baik, C.S.; Chai, Y.G.; Jung, K.H.; Park, K.S.; Roh, W.; Kim, K.S.; Kim, S.H. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2010, 472, 94–98. [Google Scholar] [CrossRef] [PubMed]
- Gornall, J. Stem cell renegades or pioneers? BMJ 2010, 340, c2041. [Google Scholar] [CrossRef] [PubMed]
- Mazzini, L.; Mareschi, K.; Ferrero, I.; Vassallo, E.; Oliveri, G.; Nasuelli, N.; Oggioni, G.D.; Testa, L.; Fagioli, F. Stem cell treatment in Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 2008, 265, 78–83. [Google Scholar] [CrossRef] [PubMed]
- Savitz, S.I.; Rosenbaum, D.M.; Dinsmore, J.H.; Wechsler, L.R.; Caplan, L.R. Cell transplantation for stroke. Ann. Neurol. 2002, 52, 266–275. [Google Scholar] [CrossRef] [PubMed]
- Cui, X.; Chopp, M.; Zacharek, A.; Roberts, C.; Lu, M.; Savant-Bhonsale, S.; Chen, J. Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke. Neurobiol. Dis. 2009, 36, 35–41. [Google Scholar] [CrossRef] [PubMed]
- Hayase, M.; Kitada, M.; Wakao, S.; Itokazu, Y.; Nozaki, K.; Hashimoto, N.; Takagi, Y.; Dezawa, M. Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J. Cerebr. Blood Flow Metabol. 2009, 29, 1409–1420. [Google Scholar] [CrossRef] [PubMed]
- Liu, Z.; Li, Y.; Zhang, X.; Savant-Bhonsale, S.; Chopp, M. Contralesional axonal remodeling of the corticospinal system in adult rats after stroke and bone marrow stromal cell treatment. Stroke 2008, 39, 2571–2577. [Google Scholar] [CrossRef] [PubMed]
- Chen, J.; Li, Y.; Katakowski, M.; Chen, X.; Wang, L.; Lu, D.; Lu, M.; Gautam, S.C.; Chopp, M. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J. Neurosci. Res. 2003, 73, 778–786. [Google Scholar] [CrossRef] [PubMed]
- Zhao, M.Z.; Nonoguchi, N.; Ikeda, N.; Watanabe, T.; Furutama, D.; Miyazawa, D.; Funakoshi, H.; Kajimoto, Y.; Nakamura, T.; Dezawa, M.; Shibata, M.A.; Otsuki, Y.; Coffin, R.S.; Liu, W.D.; Kuroiwa, T.; Miyatake, S. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J. Cerebr. Blood Flow Metabol. 2006, 26, 1176–1188. [Google Scholar] [CrossRef] [PubMed]
- Haas, S.; Weidner, N.; Winkler, J. Adult stem cell therapy in stroke. Curr. Opin. Neurol. 2005, 18, 59–64. [Google Scholar] [CrossRef] [PubMed]
- Roh, J.K.; Jung, K.H.; Chu, K. Adult stem cell transplantation in stroke: its limitations and prospects. Curr. Stem Cell Res. Ther. 2008, 3, 185–196. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; McIntosh, K.; Chen, J.; Zhang, C.; Gao, Q.; Borneman, J.; Raginski, K.; Mitchell, J.; Shen, L.; Zhang, J.; Lu, D.; Chopp, M. Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats. Exp. Neurol. 2006, 198, 313–325. [Google Scholar] [CrossRef] [PubMed]
- Zhang, C.; Li, Y.; Chen, J.; Gao, Q.; Zacharek, A.; Kapke, A.; Chopp, M. Bone marrow stromal cells upregulate expression of bone morphogenetic proteins 2 and 4, gap junction protein connexin-43 and synaptophysin after stroke in rats. Neuroscience 2006, 141, 687–695. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; Chen, J.; Zhang, C.L.; Wang, L.; Lu, D.; Katakowski, M.; Gao, Q.; Shen, L.H.; Zhang, J.; Lu, M.; Chopp, M. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005, 49, 407–417. [Google Scholar] [CrossRef] [PubMed]
- Kubinova, S.; Sykova, E. Nanotechnology for treatment of stroke and spinal cord injury. Nanomedicine (Lond) 2010, 5, 99–108. [Google Scholar] [CrossRef] [PubMed]
- Lu, M.; Chen, J.; Lu, D.; Yi, L.; Mahmood, A.; Chopp, M. Global test statistics for treatment effect of stroke and traumatic brain injury in rats with administration of bone marrow stromal cells. J. Neurosci. Meth. 2003, 128, 183–190. [Google Scholar] [CrossRef]
- Hicks, A.; Schallert, T.; Jolkkonen, J. Cell-based therapies and functional outcome in experimental stroke. Cell Stem Cell 2009, 5, 139–140. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; Chopp, M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci. Lett. 2009, 456, 120–123. [Google Scholar] [CrossRef] [PubMed]
- Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663–676. [Google Scholar] [CrossRef] [PubMed]
- Ogawa, Y.; Sawamoto, K.; Miyata, T.; Miyao, S.; Watanabe, M.; Nakamura, M.; Bregman, B.S.; Koike, M.; Uchiyama, Y.; Toyama, Y.; Okano, H. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J. Neurosci. Res. 2002, 69, 925–933. [Google Scholar] [CrossRef] [PubMed]
- Perrier, A.L.; Tabar, V.; Barberi, T.; Rubio, M.E.; Bruses, J.; Topf, N.; Harrison, N.L.; Studer, L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2004, 101, 12543–12548. [Google Scholar] [CrossRef] [PubMed]
- Nisbet, D.R.; Moses, D.; Gengenbach, T.R.; Forsythe, J.S.; Finkelstein, D.I.; Horne, M.K. Enhancing neurite outgrowth from primary neurones and neural stem cells using thermoresponsive hydrogel scaffolds for the repair of spinal cord injury. J. Biomed. Mater. Res. A 2009, 89A, 24–35. [Google Scholar] [CrossRef] [PubMed]
- Song, S.J.; Song, S.J.; Zhang, H.L.; Cuevas, J.; Sanchez-Ramos, J. Comparison of neuron-like cells derived from bone marrow stem cells to those differentiated from adult brain neural stem cells. Stem Cells Dev. 2007, 16, 747–756. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.; Shamy, G.A.; Elkabetz, Y.; Schofield, C.M.; Harrsion, N.L.; Panagiotakos, G.; Socci, N.D.; Tabar, V.; Studer, L. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 2007, 25, 1931–1939. [Google Scholar] [CrossRef] [PubMed]
- Keirstead, H.S.; Nistor, G.; Bernal, G.; Totoiu, M.; Cloutier, F.; Sharp, K.; Steward, O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 2005, 25, 4694–4705. [Google Scholar] [CrossRef] [PubMed]
- Ronsyn, M.W.; Daans, J.; Spaepen, G.; Chatterjee, S.; Vermeulen, K.; D'Haese, P.; Van Tendeloo, V.F.; Van Marck, E.; Ysebaert, D.; Berneman, Z.N.; Jorens, P.G.; Ponsaerts, P. Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC Biotechnol. 2007, 7, 90. [Google Scholar] [CrossRef] [PubMed]
- Roy, N.S.; Cleren, C.; Singh, S.K.; Yang, L.; Beal, M.F.; Goldman, S.A. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 2006, 12, 1259–1268. [Google Scholar] [CrossRef] [PubMed]
© 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Share and Cite
Wu, Y.-P.; Chen, W.-S.; Teng, C.; Zhang, N. Stem Cells for the Treatment of Neurodegenerative Diseases. Molecules 2010, 15, 6743-6758. https://doi.org/10.3390/molecules15106743
Wu Y-P, Chen W-S, Teng C, Zhang N. Stem Cells for the Treatment of Neurodegenerative Diseases. Molecules. 2010; 15(10):6743-6758. https://doi.org/10.3390/molecules15106743
Chicago/Turabian StyleWu, Yong-Ping, Wei-Shan Chen, Chong Teng, and Ning Zhang. 2010. "Stem Cells for the Treatment of Neurodegenerative Diseases" Molecules 15, no. 10: 6743-6758. https://doi.org/10.3390/molecules15106743